Cargando…
NLRP3-Inflammasome Inhibition with IZD334 Does Not Reduce Cardiac Damage in a Pig Model of Myocardial Infarction
NLRP3-inflammasome-mediated signaling is thought to significantly contribute to the extent of myocardial damage after myocardial infarction (MI). The purpose of this study was to investigate the effects of the NLRP3-inflammasome inhibitor IZD334 on cardiac damage in a pig model of myocardial infarct...
Autores principales: | Silvis, Max J. M., Demkes, Evelyne J., Timmers, Leo, Arslan, Fatih, de Jager, Saskia C. A., Sluijter, Joost P. G., Mosterd, Arend, de Kleijn, Dominique P. V., Bosch, Lena, van Hout, Gerardus P. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775177/ https://www.ncbi.nlm.nih.gov/pubmed/36551811 http://dx.doi.org/10.3390/biomedicines10123056 |
Ejemplares similares
-
Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction
por: Silvis, Max J. M., et al.
Publicado: (2020) -
Neutral Effects of Combined Treatment With GLP-1R Agonist Exenatide and MR Antagonist Potassium Canrenoate on Cardiac Function in Porcine and Murine Chronic Heart Failure Models
por: Demkes, Evelyne J., et al.
Publicado: (2021) -
Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success
por: Silvis, Max J. M., et al.
Publicado: (2020) -
Requirements for Proper Immunosuppressive Regimens to Limit Translational Failure of Cardiac Cell Therapy in Preclinical Large Animal Models
por: Demkes, Evelyne J., et al.
Publicado: (2020) -
Experimental parameters and infarct size in closed chest pig LAD ischemia reperfusion models; lessons learned
por: Silvis, Max J. M., et al.
Publicado: (2021)